Management of a Patient with Normal Bone Mineral Density and Incidental Findings

Understanding the Current BMD Results

The patient's BMD results show T-scores within normal limits, indicating a low fracture risk, according to the American College of Radiology guidelines 1, 2
Degenerative changes noted in the lumbar spine, sacroiliac joints, and hip joints are common findings that can lead to falsely elevated BMD values in the spine, as reported by the American College of Radiology 3

No immediate repeat BMD testing is needed for patients with normal BMD unless specific risk factors for accelerated bone loss develop, as recommended by the American College of Radiology 4
The American College of Radiology guidelines state that BMD measurements do not need to be repeated routinely in patients with normal BMD or mild osteopenia unless risk factors develop, with a recommended interval of about 2 years for follow-up testing 5, 3

For incidental findings such as degenerative changes in the lumbar spine, sacroiliac joints, and hip joints, no specific intervention is typically required unless symptomatic, according to the American College of Radiology guidelines 3, 5
Colonic diverticulosis requires clinical correlation, and if asymptomatic, routine monitoring is typically sufficient, as recommended by the American College of Radiology 5
Aortic vascular calcification may indicate increased cardiovascular risk, and consideration of cardiovascular risk assessment is recommended by the American College of Radiology 5

Earlier follow-up (1-2 years) should be considered if risk factors such as initiation of medications known to adversely affect BMD, development of conditions associated with secondary osteoporosis, or endocrine disorders that affect BMD develop, as recommended by the American College of Radiology 6, 7, 8
Significant weight loss or malnutrition is also a risk factor that warrants earlier follow-up BMD testing, according to the American College of Radiology guidelines 7

The American College of Radiology recommends avoiding overlooking the development of new risk factors that would warrant earlier BMD testing, and being cautious about interpreting BMD results in the presence of degenerative changes 5, 4, 3
Scanning intervals of less than 1 year are generally discouraged due to the slow nature of bone density changes, as stated by the American College of Radiology guidelines 4

The American College of Radiology suggests that initiation of medications known to adversely affect bone mineral density, such as glucocorticoid therapy, androgen deprivation therapy, aromatase inhibitor therapy, anticonvulsant drugs, and chronic heparin use, may require earlier follow-up bone mineral density testing 9
Development of medical conditions that could alter bone mineral density, including chronic renal failure, rheumatoid arthritis, eating disorders, organ transplantation, prolonged immobilization, gastrointestinal malabsorption or malnutrition, and endocrine disorders, may necessitate earlier follow-up bone mineral density testing 9
The development of hypogonadism may also require earlier follow-up bone mineral density testing, as suggested by guidelines from the American College of Radiology and the National Comprehensive Cancer Network 9, 10

For liver transplant patients with normal bone mineral density, the Journal of Hepatology recommends screening every 2-3 years 11
For cancer survivors with normal bone mineral density who are on treatments that may affect bone health, more frequent monitoring (every 1-2 years) is recommended by Cancer Treatment Reviews 12
For men under 50 and premenopausal women with normal bone mineral density but risk factors, follow-up is typically recommended every 2 years, according to the American College of Radiology 9